Effects of intravenous dichloromethylene bisphosphonate (CL2MBP) in the treatment of Paget's disease of bone.
Eyres
K S
KS
WHO Collaborating Centre for Metabolic Bone Disease, University of Sheffield, England.
McCloskey
E V
EV
Fern
E D
ED
Khan
S
S
Kanis
J A
JA
D000368:Aged; D004002:Clodronic Acid / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010001:Osteitis Deformans / Q000188:drug therapy*; D016896:Treatment Outcome
D004002:Clodronic Acid